Popular Trials
Procedure
Histotripsy with HistoSonics System for Liver Cancer
Recruiting1 award1 criteria
Miami, Florida
This trial tests a device that uses sound waves to break down liver tumors. It targets patients with liver tumors that may not respond to other treatments. The device works by creating bubbles in the tumor, which then burst and destroy the tumor cells.
Radiation Therapy
Short-Course Radiation for Breast Cancer
Recruiting1 award8 criteria
London, Ontario
This trial is testing whether giving radiation in three fractions to high-risk breast cancer patients before standard of care treatment (neoadjuvant chemotherapy and surgery) can help the patients' immune system better fight the cancer.
Popular Filters
Trials With No Placebo
Behavioral Intervention
Prophylactic Swallow Intervention for Head and Neck Cancer
Recruiting1 award4 criteria
Miami, Florida
This trial will compare the effectiveness of PRO-ACTIVE (high and low intensity) versus RE-ACTIVE swallowing therapy among 952 patients with HNC planning to undergo RT, using duration of feeding tube dependence after RT as the primary outcome.
Radiation Therapy
Radiation Therapy Schedules for Breast Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is comparing two different treatment schedules for women who need radiation therapy to their lymph nodes as part of their breast cancer treatment. One schedule takes 6 weeks and the other takes 4 weeks. The purpose of the trial is to see if the shorter schedule will lower the risk of developing arm swelling, also known as lymphedema, after radiation treatment.
Radiation Therapy
MR-Guided Radiation Therapy for Cancer
Recruiting1 award3 criteria
Toronto, Ontario
This trial is testing a new type of cancer treatment that uses magnetic resonance to guide the radiation. They want to see if it works well and if it affects the workflow of the people administering the treatment.
TGF-beta Receptor Kinase Inhibitor
Galunisertib + Chemotherapy for Rectal Cancer
Recruiting1 awardPhase 2
Portland, Oregon
This trial is testing a new drug to treat rectal cancer in combination with chemotherapy and radiation. Tissue and blood samples will also be collected to study the effectiveness of the drug and the immune system's response.
Alkylating agents
SVZ Radiation + Temozolomide for Glioblastoma
Recruiting2 awardsPhase 2
Washington, District of Columbia
This trial tests if giving extra radiation to a specific brain area along with standard cancer treatment can help control glioblastoma for a longer time in newly diagnosed patients. The treatment for newly diagnosed glioblastoma changed when radiation therapy plus temozolomide chemotherapy replaced radiation therapy alone.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.